Dibbens and colleagues later reported that in a population of children with FS and genetic epilepsy with FS plus (GEFS+), the rate of appearance of an HCN2 variant characterized by a triple proline deletion (delPPP, p.719–721) was significantly higher than in the general population. The gene discussed is HCN2; the disease is Feingold syndrome.